Pluri Inc. - Report Publication Announcement 2021

Pluristem Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical Readout false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	08/07/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-114597	Time of broadcast: 14:41 14:39:12

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPluristem Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical Readout

ea1439268k_pluristemEDGAR1_bannerless_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 15/06/2021
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected] Company site: www.pluristem.com

Previous names of reporting entity:

Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1

AI assistant